Augmentation of antiproteinuric effect by combined therapy with angiotensin II receptor blocker plus calcium channel blocker in a hypertensive patient with IgA glomerulonephritis

This publication has 19 references indexed in Scilit:

• Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
  Kidney International, 2000
• Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy
  American Journal of Kidney Diseases, 1999
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
  Journal Of Hypertension, 1999
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
  The Lancet, 1998
• Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
  Kidney International, 1997
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  The Lancet, 1997
• Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
  New England Journal of Medicine, 1996
• Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats
  Kidney International, 1995
• The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
  New England Journal of Medicine, 1993
• Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure
  Kidney International, 1992